Facebook Linkedin Twitter
Inside Precision Medicine Consortium Seeks Regulatory Qualification of Biomarkers for Knee OA

Prognosis

The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has launched a project designed to seek regulatory qualification of new biomarkers that predict the change in joint damage over time from osteoarthritis (OA) in the knee. [Source: American Academy of Orthopaedic Surgeons]
News & Features

Consortium Seeks Regulatory Qualification of Biomarkers for Knee OA

0
Head pain Attack, man suffering from brain pain. 3D illustration
Molecular Dx

Traumatic Brain Injury Biomarker Could Aid Outcome Prognosis

0
Wave Life Sciences will use Deep Genomics’ machine learning-driven biomedical platform to discover novel therapies for treating genetic neuromuscular disorders. Wave is already assessing a Duchenne muscular dystrophy (pictured) candidate in a gklobal Phase I study.[Courtney Young
Molecular Dx

Wave to Use Deep Genomics’ AI Platform in Drug Discovery Collaboration

0
Riding waves of nausea
Molecular Dx

Genes Responsible for Extreme Form of Morning Sickness Identified

0
Source: Christoph Bock/Max Planck Institute for Informatics
Molecular Dx

Cancer Prognosis and Survival Predictions Aided by DNA Methylation Patterns

0
Source: bayhayalet / Getty Images
News & Features

Op-Ed: The Value of Precision Medicine, Quantified

Panna Sharma and Jared Jacobson
0
Clinical OMICs Magazine: Volume 3
Molecular Dx

A Global Phosphorylation Assay

Ian Pike and Emma Lahert
0
1...678Page 8 of 8

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine